Global Hepatitis B Virus [HBV] Treatment Market: Opportunities and Forecast (2017-2022) - PowerPoint PPT Presentation

Loading...

PPT – Global Hepatitis B Virus [HBV] Treatment Market: Opportunities and Forecast (2017-2022) PowerPoint presentation | free to download - id: 896c05-OTZjO



Loading


The Adobe Flash plugin is needed to view this content

Get the plugin now

View by Category
About This Presentation
Title:

Global Hepatitis B Virus [HBV] Treatment Market: Opportunities and Forecast (2017-2022)

Description:

Over the recent years, the global Hepatitis B Treatment industry has been driven by the increasing number of patients. For more mail: info@azothanalytics.com – PowerPoint PPT presentation

Number of Views:16
Slides: 31
Provided by: azothanalytics
Category: Other

less

Write a Comment
User Comments (0)
Transcript and Presenter's Notes

Title: Global Hepatitis B Virus [HBV] Treatment Market: Opportunities and Forecast (2017-2022)


1
Global Hepatitis B Virus HBV Treatment Market -
Analysis By Type (Therapeutics, Vaccine), By End
User (Male, Female) - By Region, By Country
Opportunities and Forecast (2017-2022)
  • By Region- North America, Europe, APAC and RoW
  • By Country - United States, Canada, United
    Kingdom, Germany, France, China, India, Japan
  • Company Analysis

February 2018
2
Global Hepatitis B Virus HBV Treatment Market -
Analysis By Type (Therapeutics, Vaccine), By End
User (Male, Female) - By Region, By Country
Opportunities and Forecast (2017-2022)
  • g
  • Scope of the Study
  • Country Coverage
  • Regional Coverage

By Type- Therapeutics and Vaccine By End Users-
Male and Female
Product Coverage
Country Coverage
Company Coverage
Regional Coverage
  • North America
  • Europe
  • Asia-Pacific
  • ROW
  • USA
  • Canada
  • U.K.
  • Germany
  • France
  • China
  • Japan
  • India
  • Merck and Co
  • Gilead Sciences
  • Novartis AG
  • GlaxoSmithKline, plc
  • Hoffmann- La Roche
  • Bristol-Myers Squibb
  • Global Hepatitis B virus Treatment Market
    Historical (2012-2016), By Value
  • Global Hepatitis B virus Treatment Market
    Forecast (2017-2022), By Value
  • Global Hepatitis B virus Treatment Market, By
    Type (2012-2022), By Value
  • Global Hepatitis B virus Treatment Market, By End
    User (2012-2022), By Value
  • Hepatitis B virus Treatment Market, By Type
    (2012-2022), By Value
  • Hepatitis B virus Treatment Market, By End User
    (2012-2022), By Value
  • Hepatitis B virus Treatment Market, By Type
    (2012-2022), By Value
  • Hepatitis B virus Treatment Market, By End User
    (2012-2022), By Value
  • Product Benchmarking
  • Policy and Regulatory Landscape
  • Financial Analysis
  • Sales
  • EBITDA
  • PAT
  • PBT
  • Business Strategy

2
3
Table of Content
S.No Particulars Particulars Page No.
1. Research Methodology Research Methodology Research Methodology 23
2. Executive Summary Executive Summary Executive Summary 24
3. Strategic Recommendation Strategic Recommendation Strategic Recommendation 25
3.1 Asia Pacific Region to witness the fastest growth for Hepatitis B market in the forecast period Asia Pacific Region to witness the fastest growth for Hepatitis B market in the forecast period 26
3.2 Therapeutic segment witnessing fastest growth Therapeutic segment witnessing fastest growth 27
4. Hepatitis B Treatment Market Product Outlook Hepatitis B Treatment Market Product Outlook Hepatitis B Treatment Market Product Outlook 28
5. Global Hepatitis B Treatment Market Growth and Forecast Global Hepatitis B Treatment Market Growth and Forecast Global Hepatitis B Treatment Market Growth and Forecast 33
5.1 Global Hepatitis B Treatment Market, By Value (2012-2016) Global Hepatitis B Treatment Market, By Value (2012-2016) 34
5.2 Global Hepatitis B Treatment Market, By Value (2017-2022) Global Hepatitis B Treatment Market, By Value (2017-2022) 37
5.3 Global Hepatitis B Treatment Market - By Type, By Value Global Hepatitis B Treatment Market - By Type, By Value 38
5.3.1 Global Hepatitis B Treatment Market, By Value, (2016) 38
5.3.2 Global Hepatitis B Treatment Market, By Value, (Forecast 2022F) 39
5.4 Global Hepatitis B Treatment Market, By Type, By Value (2012-2022) Global Hepatitis B Treatment Market, By Type, By Value (2012-2022) 40
5.4.1 Therapeutics, By Value (2012-2022) 40
5.4.2 Vaccines, By Value (2012-2022) 40
5.5 Global Hepatitis B Treatment Market, By End-User, By Value (2012-2022) Global Hepatitis B Treatment Market, By End-User, By Value (2012-2022) 42
5.5.1 Male, By Value (2012-2022) 42
5.5.2 Female, By Value (2012-2022) 42
3
4
Table of Content
S.No Particulars Particulars Page No.
6. North America Hepatitis B Treatment Market Growth and Forecast North America Hepatitis B Treatment Market Growth and Forecast North America Hepatitis B Treatment Market Growth and Forecast 47
6.1 North America Hepatitis B Treatment Market, By Value (2012-2016) North America Hepatitis B Treatment Market, By Value (2012-2016) 48
6.2 North America Hepatitis B Treatment Market, By Value (2017-2022) North America Hepatitis B Treatment Market, By Value (2017-2022) 48
6.3 North America Hepatitis B Treatment Market - By Type, By Value North America Hepatitis B Treatment Market - By Type, By Value 51
6.3.1 North America Hepatitis B Treatment Market, By Value, (2016) 51
6.3.2 North America Hepatitis B Treatment Market, By Value, (Forecast 2022F) 52
6.4 North America Hepatitis B Treatment Market, By Type, By Value (2012-2022) North America Hepatitis B Treatment Market, By Type, By Value (2012-2022) 53
6.4.1 Therapeutics, By Value (2012-2022) 53
6.4.2 Vaccines, By Value (2012-2022) 53
6.5 North America Hepatitis B Treatment Market, By End-User, By Value (2012-2022) North America Hepatitis B Treatment Market, By End-User, By Value (2012-2022) 54
6.5.1 Male, By Value (2012-2022) 54
6.5.2 Female, By Value (2012-2022) 54
6.6 North America Hepatitis B Treatment Market Country Analysis (U.S., Canada) North America Hepatitis B Treatment Market Country Analysis (U.S., Canada) 55
6.6.1 North America Hepatitis B Treatment Market, Country Share, 2016 ( of Total) 55
6.6.2 North America Hepatitis B Treatment Market, Country Share, 2022 ( of Total) 55
4
5
Table of Content
S. No Particulars Particulars Page No.
6.7 U.S. Hepatitis B Treatment Market Growth and Forecast U.S. Hepatitis B Treatment Market Growth and Forecast 57
6.7.1 U.S. Hepatitis B Treatment Market, By Value (2012-2016) 58
6.7.2 U.S. Hepatitis B Treatment Market, By Value (2017-2022) 58
6.8 U.S. Hepatitis B Treatment Market - By Type, By Value U.S. Hepatitis B Treatment Market - By Type, By Value 62
6.8.1 Therapeutics, By Value (2012-2022) 62
6.8.2 Vaccines, By Value (2012-2022) 62
6.9 U.S. Hepatitis B Treatment Market - By End-User, By Value U.S. Hepatitis B Treatment Market - By End-User, By Value 63
6.9.1 Male, By Value (2012-2022) 63
6.9.2 Female, By Value (2012-2022) 63
6.10 Canada Hepatitis B Treatment Market Growth and Forecast Canada Hepatitis B Treatment Market Growth and Forecast 65
6.10.1 Canada Hepatitis B Treatment Market, By Value (2012-2016) 66
6.10.2 Canada Hepatitis B Treatment Market, By Value (2017-2022) 66
6.11 Canada Hepatitis B Treatment Market - By Type, By Value Canada Hepatitis B Treatment Market - By Type, By Value 69
6.11.1 Therapeutics, By Value (2012-2022) 69
6.11.2 Vaccines, By Value (2012-2022) 69
6.12 Canada Hepatitis B Treatment Market - By End-User, By Value Canada Hepatitis B Treatment Market - By End-User, By Value 70
6.12.1 Male, By Value (2012-2022) 70
6.12.2 Female, By Value (2012-2022) 70
5
6
Table of Content
S.No Particulars Particulars Page No.
7. Europe Hepatitis B Treatment Market Growth and Forecast Europe Hepatitis B Treatment Market Growth and Forecast Europe Hepatitis B Treatment Market Growth and Forecast 71
7.1 Europe Hepatitis B Treatment Market, By Value (2012-2016) Europe Hepatitis B Treatment Market, By Value (2012-2016) 72
7.2 Europe Hepatitis B Treatment Market, By Value (2017-2022) Europe Hepatitis B Treatment Market, By Value (2017-2022) 72
7.3 Europe Hepatitis B Treatment Market - By Type, By Value Europe Hepatitis B Treatment Market - By Type, By Value 75
7.3.1 Europe Hepatitis B Treatment Market, By Value, (2016) 75
7.3.2 Europe Hepatitis B Treatment Market, By Value, (Forecast 2022F) 76
7.4 Europe Hepatitis B Treatment Market, By Type, By Value (2012-2022) Europe Hepatitis B Treatment Market, By Type, By Value (2012-2022) 77
7.4.1 Therapeutics, By Value (2012-2022) 77
7.4.2 Vaccines, By Value (2012-2022) 77
7.5 Europe Hepatitis B Treatment Market, By End-User, By Value (2012-2022) Europe Hepatitis B Treatment Market, By End-User, By Value (2012-2022) 78
7.5.1 Male, By Value (2012-2022) 78
7.5.2 Female, By Value (2012-2022) 78
6
7
Table of Content
S. No Particulars Particulars Page No.
7.6 Europe Hepatitis B Treatment Market Country Analysis (U.K., Germany, France) Europe Hepatitis B Treatment Market Country Analysis (U.K., Germany, France) 79
7.6.1 Europe Hepatitis B Treatment Market, Country Share, 2016 ( of Total) 79
7.6.2 Europe Hepatitis B Treatment Market, Country Share, 2022 ( of Total) 79
7.7 U.K. Hepatitis B Treatment Market Growth and Forecast U.K. Hepatitis B Treatment Market Growth and Forecast 81
7.7.1 U.K. Hepatitis B Treatment Market, By Value (2012-2016) 82
7.7.2 U.K. Hepatitis B Treatment Market, By Value (2017-2022) 82
7.8 U.K. Hepatitis B Treatment Market - By Type, By Value U.K. Hepatitis B Treatment Market - By Type, By Value 86
7.8.1 Therapeutics, By Value (2012-2022) 86
7.8.2 Vaccines, By Value (2012-2022) 86
7.9 U.K. Hepatitis B Treatment Market - By End-User, By Value U.K. Hepatitis B Treatment Market - By End-User, By Value 87
7.9.1 Male, By Value (2012-2022) 87
7.9.2 Female, By Value (2012-2022) 87
7.10 Germany Hepatitis B Treatment Market Growth and Forecast Germany Hepatitis B Treatment Market Growth and Forecast 88
7.10.1 Germany Hepatitis B Treatment Market, By Value (2012-2016) 89
7.10.2 Germany Hepatitis B Treatment Market, By Value (2017-2022) 89
7
8
Table of Content
S. No Particulars Particulars Page No.
7.11 Germany Hepatitis B Treatment Market - By Type, By Value Germany Hepatitis B Treatment Market - By Type, By Value 92
7.11.1 Therapeutics, By Value (2012-2022) 92
7.11.2 Vaccines, By Value (2012-2022) 92
7.12 Germany Hepatitis B Treatment Market - By End-User, By Value Germany Hepatitis B Treatment Market - By End-User, By Value 93
7.12.1 Male, By Value (2012-2022) 93
7.12.2 Female, By Value (2012-2022) 93
7.13 France Hepatitis B Treatment Market Growth and Forecast France Hepatitis B Treatment Market Growth and Forecast 94
7.13.1 France Hepatitis B Treatment Market, By Value (2012-2016) 95
7.13.2 France Hepatitis B Treatment Market, By Value (2017-2022) 95
7.14 France Hepatitis B Treatment Market - By Type, By Value France Hepatitis B Treatment Market - By Type, By Value 98
7.14.1 Therapeutics, By Value (2012-2022) 98
7.14.2 Vaccines, By Value (2012-2022) 98
7.15 France Hepatitis B Treatment Market - By End-User, By Value France Hepatitis B Treatment Market - By End-User, By Value 99
7.15.1 Male, By Value (2012-2022) 99
7.15.2 Female, By Value (2012-2022) 99
8
9
Table of Content
S.No Particulars Particulars Page No.
8. Asia-Pacific Hepatitis B Treatment Market Growth and Forecast Asia-Pacific Hepatitis B Treatment Market Growth and Forecast Asia-Pacific Hepatitis B Treatment Market Growth and Forecast 100
8.1 Asia-Pacific Hepatitis B Treatment Market, By Value (2012-2016) Asia-Pacific Hepatitis B Treatment Market, By Value (2012-2016) 101
8.2 Asia-Pacific Hepatitis B Treatment Market, By Value (2017-2022) Asia-Pacific Hepatitis B Treatment Market, By Value (2017-2022) 101
8.3 Asia-Pacific Hepatitis B Treatment Market - By Type, By Value Asia-Pacific Hepatitis B Treatment Market - By Type, By Value 103
8.3.1 Asia-Pacific Hepatitis B Treatment Market, By Value, (2016) 103
8.3.2 Asia-Pacific Hepatitis B Treatment Market, By Value, (Forecast 2022F) 104
8.4 Asia-Pacific Hepatitis B Treatment Market, By Type, By Value (2012-2022) Asia-Pacific Hepatitis B Treatment Market, By Type, By Value (2012-2022) 105
8.4.1 Therapeutics, By Value (2012-2022) 105
8.4.2 Vaccines, By Value (2012-2022) 105
8.5 Asia-Pacific Hepatitis B Treatment Market, By End-User, By Value (2012-2022) Asia-Pacific Hepatitis B Treatment Market, By End-User, By Value (2012-2022) 106
8.5.1 Male, By Value (2012-2022) 106
8.5.2 Female, By Value (2012-2022) 106
8.6 Asia-Pacific Hepatitis B Treatment Market Country Analysis (Japan, China, India) Asia-Pacific Hepatitis B Treatment Market Country Analysis (Japan, China, India) 107
9
10
Table of Content
S. No Particulars Particulars Page No.
8.6.1 Asia-Pacific Hepatitis B Treatment Market, Country Share, 2016 ( of Total) 107
8.6.2 Asia-Pacific Hepatitis B Treatment Market, Country Share, 2022 ( of Total) 107
8.7 Japan Hepatitis B Treatment Market Growth and Forecast Japan Hepatitis B Treatment Market Growth and Forecast 109
8.7.1 Japan Hepatitis B Treatment Market, By Value (2012-2016) 110
8.7.2 Japan Hepatitis B Treatment Market, By Value (2017-2022) 110
8.8 Japan Hepatitis B Treatment Market - By Type, By Value Japan Hepatitis B Treatment Market - By Type, By Value 113
8.8.1 Therapeutics, By Value (2012-2022) 113
8.8.2 Vaccines, By Value (2012-2022) 113
8.9 Japan Hepatitis B Treatment Market - By End-User, By Value Japan Hepatitis B Treatment Market - By End-User, By Value 114
8.9.1 Male, By Value (2012-2022) 114
8.9.2 Female, By Value (2012-2022) 114
8.10 China Hepatitis B Treatment Market Growth and Forecast China Hepatitis B Treatment Market Growth and Forecast 115
8.10.1 China Hepatitis B Treatment Market, By Value (2012-2016) 116
8.10.2 China Hepatitis B Treatment Market, By Value (2017-2022) 116
10
11
Table of Content
S. No Particulars Particulars Page No.
8.11 China Hepatitis B Treatment Market - By Type, By Value China Hepatitis B Treatment Market - By Type, By Value 119
8.11.1 Therapeutics, By Value (2012-2022) 119
8.11.2 Vaccines, By Value (2012-2022) 119
8.12 China Hepatitis B Treatment Market - By End-User, By Value China Hepatitis B Treatment Market - By End-User, By Value 120
8.12.1 Male, By Value (2012-2022) 120
8.12.2 Female, By Value (2012-2022) 120
8.13 India Hepatitis B Treatment Market Growth and Forecast India Hepatitis B Treatment Market Growth and Forecast 122
8.13.1 India Hepatitis B Treatment Market, By Value (2012-2016) 123
8.13.2 India Hepatitis B Treatment Market, By Value (2017-2022) 123
8.14 India Hepatitis B Treatment Market - By Type, By Value India Hepatitis B Treatment Market - By Type, By Value 126
8.14.1 Therapeutics, By Value (2012-2022) 126
8.14.2 Vaccines, By Value (2012-2022) 126
8.15 India Hepatitis B Treatment Market - By End-User, By Value India Hepatitis B Treatment Market - By End-User, By Value 127
8.15.1 Male, By Value (2012-2022) 127
8.15.2 Female, By Value (2012-2022) 127
11
12
Table of Content
S. No Particulars Page No.
9. ROW Hepatitis B Treatment Market Growth and Forecast ROW Hepatitis B Treatment Market Growth and Forecast ROW Hepatitis B Treatment Market Growth and Forecast 128
9.1 ROW Hepatitis B Treatment Market, By Value (2012-2016) ROW Hepatitis B Treatment Market, By Value (2012-2016) 129
9.2 ROW Hepatitis B Treatment Market, By Value (2017-2022) ROW Hepatitis B Treatment Market, By Value (2017-2022) 129
10. Market Dynamics Market Dynamics Market Dynamics 132
10.1 Increasing prevalence of Liver diseases due to Hepatitis B Increasing prevalence of Liver diseases due to Hepatitis B 134
10.2 Increasing awareness about the Hepatitis B HBV Increasing awareness about the Hepatitis B HBV 135
10.3 Rising healthcare expenditure worldwide Rising healthcare expenditure worldwide 136
11. Market Restraints Market Restraints Market Restraints 137
12. SWOT Analysis Hepatitis B Treatment Market SWOT Analysis Hepatitis B Treatment Market SWOT Analysis Hepatitis B Treatment Market 141
13. Porters Five Forces Analysis Porters Five Forces Analysis Porters Five Forces Analysis 143
14. Policy and Regulations Policy and Regulations Policy and Regulations 145
15. Global Hepatitis B Drugs Pipeline Global Hepatitis B Drugs Pipeline Global Hepatitis B Drugs Pipeline 153
16. Global Hepatitis B Treatment Market - Competitive Landscape Global Hepatitis B Treatment Market - Competitive Landscape Global Hepatitis B Treatment Market - Competitive Landscape 159
12
13
Table of Content
S. No Particulars Page No.
17. Company Profile Company Profile Company Profile 161
17.1 Merck and Co Merck and Co 162
17.2 Gilead Sciences Gilead Sciences 165
17.3 Novartis AG Novartis AG 167
17.4 GlaxoSmithKline, plc GlaxoSmithKline, plc 169
17.5 F.Hoffmann- La Roche F.Hoffmann- La Roche 172
17.6 Bristol-Myers Squibb Bristol-Myers Squibb 175
17.7 AbbVie Inc AbbVie Inc 179
18. About US About US About US 181
13
14
List of Figures
Figure No. Figure Title Page No.
Figure 1 Global Hepatitis B Treatment Market Size, By Value, 2012-2016 (USD Million) 34
Figure 2 Number of patients with Hepatitis B Virus (HBsAg) infection by WHO region, 2015 (In Million) 35
Figure 3 Global Healthcare Expenditure, 2012-2016 (In Trillion) 36
Figure 4 Global Hepatitis B Treatment Market Size, By Value, 2017-2022 (USD Million) 37
Figure 5 Global Hepatitis B Treatment Market Size, By Type, 2016 () 38
Figure 6 Global Hepatitis B Treatment Market Size, By Type, 2022 () 39
Figure 7 Global Hepatitis B Treatment Market- By Type, By Value 2012-2022 (USD Million) 40
Figure 8 Global Hepatitis B Treatment Market- By End-User, By Value 2012-2022 (USD Million) 42
Figure 9 Global Sales of HBV approved Drugs, By Value, 2014-2016 (USD Million) 43
Figure 10 Global Sales of Viread, By Value, 2015-2016 (USD Million) 43
Figure 11 Global Hepatitis B Treatment Market Size, By Region, 2016 () 45
Figure 12 Global Hepatitis B Treatment Market Size, By Region, 2022 () 46
Figure 13 North America Hepatitis B Treatment Market Size, By Value, 2012-2022 (USD Million) 48
Figure 14 North America GDP, 2012-2015 (USD Trillion) 49
Figure 15 North America GDP, By Select Country, 2016 (USD Trillion) 49
Figure 16 Population aged 65 above, 2012-2016 ( of total) 50
Figure 17 North America Hepatitis B Treatment Market Size, By Type, 2016 () 51
Figure 18 North America Hepatitis B Treatment Market Size, By Type, 2022 () 52
Figure 19 North America Hepatitis B Treatment Market- By Type, By Value 2012-2022 (USD Million) 53
14
15
List of Figures
Figure No. Figure Title Page No.
Figure 20 North America Hepatitis B Treatment Market- By End-User, By Value 2012-2022 (USD Million) 54
Figure 21 North America Hepatitis B Treatment Market, Country Share, 2016 ( of Total) 55
Figure 22 North America Hepatitis B Treatment Market, Country Share, 2022 ( of Total) 55
Figure 23 U.S. Hepatitis B Treatment Market Size, By Value, 2012-2022 (USD Million) 58
Figure 24 U.S. Per Capita Healthcare Expenditure, 2012-2016 (In USD) 60
Figure 25 Reported acute (new) cases of Hepatitis B Virus in U.S., (2012-2015) 60
Figure 26 Incidences rate of acute Hepatitis B in U.S., By sex (2012-2015) 60
Figure 27 Incidence of acute Hepatitis B in U.S., By age group, (2012-2015) 61
Figure 28 U.S. Hepatitis B Treatment Market- By Type, By Value 2012-2022 (USD Million) 62
Figure 29 U.S. Hepatitis B Treatment Market- By End-User, By Value 2012-2022 (USD Million) 63
Figure 30 Market Share of HBV approved Drugs in U.S., 2016 ( Share) 64
Figure 31 Canada Hepatitis B Treatment Market Size, By Value, 2012-2022 (USD Million) 66
Figure 32 Canada Per Capita Healthcare Expenditure, 2012-2016 (In USD) 67
Figure 33 Canada Life Expectancy at birth rate (Years), 2012-2015 67
Figure 34 Prevalence of Hepatitis B in Canada, (Patients per 100,000 (2012-2016) 67
Figure 35 Number of Hepatitis B Patients, Canada, (2013-2016) 67
Figure 36 Prevalence of Hepatitis B among Male population, Canada, (Patients per 100,000) (2012-2016) 68
Figure 37 Prevalence of Hepatitis B among Female population, Canada, (Patients per 100,000) (2012-2016) 68
Figure 38 Canada Hepatitis B Treatment Market- By Type, By Value 2012-2022 (USD Million) 69
Figure 39 Canada Hepatitis B Treatment Market- By End-User, By Value 2012-2022 (USD Million) 70
15
16
List of Figures
Figure No. Figure Title Page No.
Figure 40 Canada Hepatitis B Treatment Market- By End-User, By Value 2012-2022 (USD Million) 72
Figure 41 European Union, Per Capita Healthcare Expenditure, 2012-2014 (In USD) 73
Figure 42 European Union Life Expectancy at birth rate (Years), 2012-2015 73
Figure 43 Reported Hepatitis B Cases, Number Rate per 100,000 populations, EU/EEA, 2012-2015 73
Figure 44 Acute Chronic Hepatitis B cases, rate per 100,000 populations, By Age Group, 2015 74
Figure 45 Acute Chronic Hepatitis B cases, rate per 100,000 populations, By Age Group, 2015 74
Figure 46 Europe Hepatitis B Treatment Market Size, By Type, 2016 () 75
Figure 47 Europe Hepatitis B Treatment Market Size, By Type, 2022 () 76
Figure 48 Europe Hepatitis B Treatment Market- By Type, By Value 2012-2022 (USD Million) 77
Figure 49 Europe Hepatitis B Treatment Market- By End-User, By Value 2012-2022 (USD Million) 78
Figure 50 Europe Hepatitis B Treatment, Country Share, 2016 ( of Total) 79
Figure 51 Europe Hepatitis B Treatment, Country Share, 2022 ( of Total) 79
Figure 52 U.K. Hepatitis B Treatment Size, By Value, 2012-2022 (USD Million) 82
Figure 53 U.K. Population 65 Years Above ( of Total), 2012-2016 84
Figure 54 U.K. Life Expectancy at birth rate (Years), 2012-2015 84
Figure 55 U.K. Women Population, 2012-2016 84
Figure 56 U.K., Per Capita Healthcare Expenditure, 2012-2014 (In USD) 84
Figure 57 Prevalence of Hepatitis B (Patients per 100,000 (2012-2016) 85
Figure 58 Number of Hepatitis B Patients, (2013-2016) 85
Figure 59 Prevalence of Hepatitis B among Male population (Patients per 100,000) (2012-2016) 85
Figure 60 Prevalence of Hepatitis B among Female population (Patients per 100,000) (2012-2016) 85
16
17
List of Figures
Figure No. Figure Title Page No.
Figure 61 U.K. Hepatitis B Treatment- By Type, By Value 2012-2022 (USD Million) 86
Figure 62 U.K. Hepatitis B Treatment- By End-User, By Value 2012-2022 (USD Million) 87
Figure 63 Germany Hepatitis B Treatment Size, By Value, 2012-2022 (USD Million) 89
Figure 64 Germany Population 65 Years Above ( of Total), 2012-2016 90
Figure 65 Germany Life Expectancy at birth rate (Years), 2012-2015 90
Figure 66 Germany Women Population, 2012-2016 90
Figure 67 Germany Per Capita Healthcare Expenditure, 2012 - 2014 (In USD) 90
Figure 68 Prevalence of Hepatitis B (Patients per 100,000 (2012-2016) 91
Figure 69 Number of Hepatitis B Patients, (2013-2016) 91
Figure 70 Prevalence of Hepatitis B among Male population (Patients per 100,000) (2012-2016) 91
Figure 71 Prevalence of Hepatitis B among Female population (Patients per 100,000) (2012-2016) 91
Figure 72 Germany Hepatitis B Treatment- By Type, By Value 2012-2022 (USD Million) 92
Figure 73 Germany Hepatitis B Treatment- By End-User, By Value 2012-2022 (USD Million) 93
Figure 74 France Hepatitis B Treatment Size, By Value, 2012-2022 (USD Million) 95
Figure 75 France Population 65 Years Above ( of Total), 2012-2016 96
Figure 76 France Life Expectancy at birth rate (Years), 2012-2015 96
Figure 77 France Women Population, 2012-2016 96
Figure 78 France Per Capita Healthcare Expenditure, 2012-2014 (In USD) 96
Figure 79 Prevalence of Hepatitis B (Patients per 100,000 (2012-2016) 97
Figure 80 Prevalence of Hepatitis B among Male population (Patients per 100,000) (2012-2016) 97
17
18
List of Figures
Figure No. Figure Title Page No.
Figure 81 Prevalence of Hepatitis B among Female population (Patients per 100,000) (2012-2016) 97
Figure 82 France Hepatitis B Treatment- By Type, By Value 2012-2022 (USD Million) 98
Figure 83 France Hepatitis B Treatment- By End-User, By Value 2012-2022 (USD Million) 99
Figure 84 Asia-Pacific Hepatitis B Treatment Size, By Value, 2012-2022 (USD Million) 101
Figure 85 Mortality due to Viral Hepatitis in South-East Asia region, 2015 102
Figure 86 Asia-Pacific Hepatitis B Treatment Size, By Type, 2016 () 103
Figure 87 Asia-Pacific Hepatitis B Drug Market Size, By Type, 2022 () 104
Figure 88 Asia-pacific Hepatitis B Treatment- By Type, By Value 2012-2022 (USD Million) 105
Figure 89 Asia-Pacific Hepatitis B Treatment- By End-User, By Value 2012-2022 (USD Million) 106
Figure 90 Asia-Pacific Hepatitis B Treatment, Country Share, 2016 ( of Total) 107
Figure 91 Asia-Pacific Hepatitis B Treatment, Country Share, 2022 ( of Total) 107
Figure 92 Japan Hepatitis B Treatment Size, By Value, 2012-2022 (USD Million) 110
Figure 93 Japan Population 65 Years Above ( of Total), 2012-2016 111
Figure 94 Japan Life Expectancy at birth rate (Years), 2012-2015 111
Figure 95 Japan, Per Capita Healthcare Expenditure, 2012-2014 (In USD) 111
Figure 96 Prevalence of Hepatitis B (Patients per 100,000 (2012-2016) 112
Figure 97 Number of Hepatitis B Patients, 2013-2016) 112
Figure 98 Prevalence of Hepatitis B among Male population (Patients per 100,000 (2012-2016) 112
Figure 99 Prevalence of Hepatitis B among Female population (Patients per 100,000 (2012-2016) 112
Figure 100 Japan Hepatitis B Treatment- By Type, By Value 2012-2022 (USD Million) 113
18
19
List of Figures
Figure No. Figure Title Page No.
Figure 101 Japan Hepatitis B Treatment- By End-User, By Value 2012-2022 (USD Million) 114
Figure 102 China Hepatitis B Treatment Size, By Value, 2012-2022 (USD Million) 116
Figure 103 China Population 65 Years Above ( of Total), 2012-2016 118
Figure 104 China Life Expectancy at birth rate (Years), 2012-2015 118
Figure 105 China Women Population, 2012-2016 118
Figure 106 China Per Capita Healthcare Expenditure, 2012-2014 (In USD) 118
Figure 107 Prevalence of Hepatitis B (Patients per 100,000 (2012-2016) 119
Figure 108 Number of Hepatitis B Patients, 2013-2016) 119
Figure 109 Prevalence of Hepatitis B among Male population (Patients per 100,000) (2012-2016) 119
Figure 110 Prevalence of Hepatitis B among Female population (Patients per 100,000) (2012-2016) 119
Figure 111 China Hepatitis B Treatment- By Type, By Value 2012-2022 (USD Million) 120
Figure 112 China Hepatitis B Treatment- By End-User, By Value 2012-2022 (USD Million) 121
Figure 113 India Hepatitis B Treatment Size, By Value, 2012-2022 (USD Million) 123
Figure 114 India Population 65 Years Above ( of Total), 2012-2016 124
Figure 115 India Life Expectancy at birth rate (Years), 2012-2015 124
Figure 116 India Women Population, 2012-2016 124
Figure 117 India Per Capita Healthcare Expenditure, 2012-2014 (In USD) 124
Figure 118 Prevalence of Hepatitis B (Patients per 100,000 (2012-2016) 125
Figure 119 Number of Hepatitis B Patients, 2013-2016) 125
Figure 120 Prevalence of Hepatitis B among Male population (Patients per 100,000) (2012-2016) 125
19
20
List of Figures
Figure No. Figure Title Page No.
Figure 121 Prevalence of Hepatitis B among Female population (Patients per 100,000) (2012-2016) 125
Figure 122 India Hepatitis B Treatment- By Type, By Value 2012-2022 (USD Million) 126
Figure 123 India Hepatitis B Treatment- By End-User, By Value 2012-2022 (USD Million) 127
Figure 124 ROW Hepatitis B Treatment Size, By Value, 2012-2022 (USD Million) 129
Figure 125 Prevalence of Hepatitis B in Brazil (Patients per 100,000 (2012-2016) 130
Figure 126 Number of Hepatitis B Patients in Brazil, (2013-2016) 130
Figure 127 Prevalence of Hepatitis B among Male population, in Brazil (Patients per 100,000) (2012-2016) 130
Figure 128 Prevalence of Hepatitis B among Female population in Brazil (Patients per 100,000) (2012-2016) 130
Figure 129 Prevalence of Hepatitis B in South Africa (Patients per 100,000 (2012-2016) 131
Figure 130 Number of Hepatitis B Patients in South Africa, (2013-2016) 131
Figure 131 Prevalence of Hepatitis B among Male population, in South Africa (Patients per 100,000) (2012-2016) 131
Figure 132 Prevalence of Hepatitis B among Female population (Patients per 100,000), in South Africa (2012-2016) 131
Figure 133 Global Healthcare Expenditure, 2012-2016 (In Trillion) 136
Figure 134 Global Sales of HBV approved Drugs, By Value, 2014-2016 (USD Million) 159
Figure 135 Global Sales of Viread, By, Region, By Value, 2015-2016 (USD Million) 159
Figure 136 Merck Co., Net Sales, 2012-2016 (In million USD) 163
Figure 137 Merck Co, Net Sales of Gardasil/Gardasil 9, 2012-2016 (In million USD) 163
Figure 138 Merck Co., Net Sales, By Geographic Location, Share 2016 163
Figure 139 Merck Co., Net Revenue, By Business Segment, Share 2016 163
Figure 140 Gilead Sciences Annual Revenue, 2014-2016 (USD Million) 166
20
21
List of Figures
Figure No. Figure Title Page No.
Figure 141 Gilead Sciences HBV Product Sales, 2014-2016 (USD Million) 166
Figure 142 Gilead Sciences Revenue by Geographical, 2016 () 166
Figure 143 Gilead Sciences Product Sales, 2016 () 166
Figure 144 Novartis Annual Revenue, 2014-2016 (USD Million) 168
Figure 145 Innovative Medicine net Sales, By Business Unit 2016 () 168
Figure 146 Novartis Sales, By Region, 2016 () 168
Figure 147 Novartis Sales, By Segment 2016 () 168
Figure 148 GlaxoSmithKline Annual Revenue, 2014-2016 (USD Million) 170
Figure 149 Sales from Hepatitis Vaccination, GlaxoSmithKline, 2015 - 2016 (USD Million) 170
Figure 150 Glaxosmithkline Sales, By Region, 2016 () 170
Figure 151 Glaxosmithkline, Sales, By Segment 2016 () 170
Figure 152 F. Hoffmann-La Roche Ltd Annual Revenue, 2014-2016 (USD Million) 173
Figure 153 F. Hoffmann-La Roche Ltd Segmental Break Up, By Revenue, By Business Division, 2016 () 173
Figure 154 F. Hoffmann-La Roche Ltd Geographical Break Up, By Revenue, 2016 () 173
Figure 155 Bristol-Myers Squibb Company Annual Revenue, 2014-2016 (USD Million) 176
Figure 156 Bristol-Myers Squibb Company Segmental Break Up, By Revenue, By Products, 2016 () 176
Figure 157 Bristol-Myers Squibb Company Geographical Break Up, By Revenue, 2016 () 176
Figure 158 Baraclude (entecavir), Annual Revenue, 2014-2016 (USD Million) 177
21
22
List of Figures
Figure No. Figure Title Page No.
Figure 159 Baraclude (entecavir), Segmental Break Up, By geographical segment, 2016 () 177
Figure 160 AbbVie Revenue, Segmental Break Up, 2016 180
Figure 161 AbbVie Revenue, Geographical Break Up, 2016 180

Table A Causes of Hepatitis B 29
Table B HBV Approved Therapies 31
Table C Globally Approved HBV Monovalent Vaccines 32
Table D Compounds in development for chronic Hepatitis B 154
22
23
Research Methodology
Companies Contacted GlaxoSmithKline
Pharmaceuticals Ltd, Mylan Laboratories India Pvt
Ltd
23
24
Global Hepatitis B Treatment Market Sizing and
Growth
High prevalence of Hepatitis B, improving access
to diagnosis coupled with growing efforts to
reduce large disease burden due to HBV infection
is propelling the global market growth rate
Figure Global Hepatitis B Treatment Market
Size, By Value, 2012-2016 (USD Million)
CAGR 2012-2016 Hepatitis B xxxx
Source Azoth Analytics Estimates
  • Xxxxx
  • Xxxxx
  • Xxxxx
  • Xxxxx
  • xxxxx

24
25
Global Hepatitis B Treatment Market - Regional
Analysis
In the forecast period, North America is
anticipated to hold its leading position in the
market. However, Asia Pacific region is expected
to grow at the highest pace.
Figure Global Hepatitis B Treatment Market
Size, By Region, 2022 ()
Source Azoth Analytics Estimates
25
26
North America Hepatitis B Treatment Market- By
Country Share
Figure North America Hepatitis B Treatment
Market, Country Share, 2022 ( of Total)
Figure North America Hepatitis B Treatment
Market, Country Share, 2016 ( of Total)
Source Azoth Analytics Estimates
Source Azoth Analytics Estimates
26
27
Europe Hepatitis B Treatment Market- By End-User,
By Value
CAGR 2012-2016 Male xx Female xx
CAGR 2017-2022 Male xx Female xx
Source Azoth Analytics Estimates
  • Xxxxx
  • Xxxxx
  • Xxxxx
  • Xxxxx
  • Xxxxxx
  • xxxxxx

27
28
China Hepatitis B Treatment Market - By Type, By
Value
CAGR 2012-2016 Therapeutics xx Vaccines xx
CAGR 2017-2022 Therapeutics xx Vaccines xx
Source Azoth Analytics Estimates
  • Xxxxx
  • Xxxxx
  • Xxxxx
  • Xxxxx
  • Xxxxx
  • xxxxx

28
29
About Azoth Analytics Pvt Ltd. Azoth Analytics
is a business research and analytics firm that
creates in-depth research reports and provides
customized research solutions and consultancy
services. Verticals in which Azoth Analytics
specializes include healthcare and
pharmaceutical, oil and gas, retail, chemicals,
automotive, FMCG, food beverages and
technology. Azoth creates comprehensive and
in-depth research reports by recording,
interpreting and analyzing information. Strategic
market sizing and data dredging techniques
include secondary research, and primary research
(interviews with management personnel and
industry experts). Related Reports Global
Oxygen Therapy Equipment Market - Analysis By
Product, Portability, Application, Region,
Country Opportunities and Forecast (2017- 2022)
-- By Product (Oxygen Concentrators, Liquid
Oxygen Devices and Oxygen Cylinders), By
Portability (Stationary, Portable Devices), By
Application (COPD, Asthma, Cystic Fibrosis,
Respiratory Distress Syndrome) Global Industrial
X-Ray Inspection System Market - By Imaging
Technique, By Digital Imaging Type, By Digital
Radiography Type, By End User, By Region, By
Country (2017-2022) -- By Imaging Technique (Film
Based, Digital), By Digital Imaging Type (Digital
Radiography, Computed Tomography), By Digital
Radiography Type (Direct Digital, Computed
Radiography) Disclaimer Azoth Analytics
report information is based mainly on interviews
and therefore, is subject to fluctuation. Azoth
Analytics therefore, takes no responsibility for
any incorrect information supplied to us by
industry experts, manufacturers or users. Azoth
does not warranty the completeness of the
information and data. Also, analysis provided in
the report are meant for customers internal use
only and not for general publication or
disclosure to third parties.
29
30
Global Hepatitis B Virus HBV Treatment Market -
Analysis By Type (Therapeutics, Vaccine), By End
User (Male, Female) - By Region, By Country
Opportunities and Forecast (2017-2022) -- By
Region (N. America, Europe, APAC, ROW), By
Country (US, Canada, UK, Germany, France, China,
India, Japan) Publish Date Feb 2018 No. of
Pages 180 Price USD 2200 (Single User License)
Price USD 3000 (Multi- User License) To View
Sample Report or Purchase Report Click Here
Contact Us
ASIA PACIFIC

EUROPE


Mail info_at_azothanalytics.com

Mail shipra_at_azothanalytics.com
Phone 91 120 429 8235

Phone 44 - 744 - 8107625
NORTH AMERICA

Call for Assistance


Mail tanvi_at_azothanalytics.com

Phone 91 9873 4262
88Phone 1 - 321 - 444 9707

Sales Enquiry  


Phone 91 120
429 8235
www.azothanalytics.com
30
About PowerShow.com